http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016024470-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fff0707be6948d22581d03b6dc5a7fcc
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-999
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-998
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-2304
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-2302
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0637
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0636
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783
filingDate 2015-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e31aad66910b24439cc10621620c365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52cd7c79022f082d8d8b3fbaa4030ee6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a21ec33b7d7b9a6ce456921f5296b37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72082b8fb4a4ac453af6ea24ecad5031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cc6419337c7b57242f5c4d719a60463
publicationDate 2016-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2016024470-A1
titleOfInvention Methods and materials for the generation of regulatory t cells
abstract Methods are disclosed for the generation of immunosuppressive regulatory T cells. The methods can include contacting a population of CD4+CD25− T cells with a T cell receptor (TCR)/CD3 activator, a TCR co-stimulator activator, and rapamycin. Kits for the generation of immunosuppressive regulatory T cells, methods of use, and cell populations are also disclosed.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3346001-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10294454-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3808766-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11512288-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019197678-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020030979-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018127585-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018127584-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021186056-A1
priorityDate 2006-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46835353
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284616
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1134
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395632
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226521892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395633

Total number of triples: 45.